FDA Orange Book · active-ingredient family
Ferric pyrophosphate citrate
Ferric pyrophosphate citrate is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:TRIFERIC AVNU · NDA 212860
3
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · powder, solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TRIFERIC AVNURLD | ROCKWELL MEDICAL INC | NDA 212860 | — | Mar 27, 2020 | |
| TRIFERICRLD | ROCKWELL MEDICAL INC | NDA 208551 | — | Apr 25, 2016 | |
| TRIFERICRLD×2 | ROCKWELL MEDICAL INC | NDA 206317 | — | Jan 23, 2015 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7857977 | Sep 08, 2027 | in 1 yr 3 mo | U-1656 |
| 7816404 | Apr 17, 2029 | in 2 yr 10 mo | U-1656 |
Ferric pyrophosphate citrate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
